International Clinical Trial: A Prospective Cohort Study of Azacitidine Combined with Luspatercept in Patients with Relatively Low-Risk Myelodysplastic Syndromes (MDS)

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120265) titled 'A Prospective Cohort Study of Azacitidine Combined with Luspatercept in Patients with Relatively Low-Risk Myelodysplastic Syndromes (MDS)' on March 11.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Beijing No.6 Hospital

Condition: Myelodysplastic syndromes

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-03-16

Target Sample Size: Azacitidine Combined with Luspatercept Group:51;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=313308

Published by HT Digital Content Services with permission fro...